Science Corporation closed a $230 million Series C to accelerate commercialization of its PRIMA brain-computer-interface retinal implant.
- Amount
- $230M
- Stage
- Series C
- Announced
- 5 March 2026
- Use of funds
- Accelerate commercialization of its PRIMA BCI retinal implant.
- Checked
- Amount and date matched across 3 press sources